These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3460220

  • 1. HLA antigens and complotypes in insulin-dependent diabetes mellitus.
    Partanen J, Koskimies S, Ilonen J, Knip M.
    Tissue Antigens; 1986 May; 27(5):291-7. PubMed ID: 3460220
    [Abstract] [Full Text] [Related]

  • 2. Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland.
    Ilonen J, Surcel HM, Partanen J, Koskimies S, Knip M, Käär ML.
    Tissue Antigens; 1988 Sep; 32(3):139-44. PubMed ID: 3217930
    [Abstract] [Full Text] [Related]

  • 3. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes.
    Rich SS, Weitkamp LR, Barbosa J.
    Am J Hum Genet; 1984 Sep; 36(5):1015-23. PubMed ID: 6594040
    [Abstract] [Full Text] [Related]

  • 4. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K, Bardi R, Gorgi Y, Jenhani F, Chammakhi S, Boukhris R.
    Dis Markers; 1989 Sep; 7(1):43-7. PubMed ID: 2714046
    [Abstract] [Full Text] [Related]

  • 5. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study.
    de Jongh BM, Bruining GJ, Schreuder GM, Schuurman RK, Radder JK, van Loghem E, Meera Khan P, Hauptmann G, van Rood JJ.
    Hum Immunol; 1984 May; 10(1):5-21. PubMed ID: 6586708
    [Abstract] [Full Text] [Related]

  • 6. Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies.
    Murphy CC, Acton RT, Barger BO, Go RC, Kirk KA, Reitnauer PJ, Roseman JM.
    Clin Genet; 1983 Jun; 23(6):405-14. PubMed ID: 6411398
    [Abstract] [Full Text] [Related]

  • 7. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
    Thomsen M, Mølvig J, Zerbib A, de Preval C, Abbal M, Dugoujon JM, Ohayon E, Svejgaard A, Cambon-Thomsen A, Nerup J.
    Immunogenetics; 1988 Jun; 28(5):320-7. PubMed ID: 3139557
    [Abstract] [Full Text] [Related]

  • 8. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B, Holmgren G, Holmlund G, Lindblom B, Olaisen B, Teisberg P.
    Hum Hered; 1986 Jun; 36(4):201-12. PubMed ID: 3639057
    [Abstract] [Full Text] [Related]

  • 9. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM, Barnard J, Farid N, Marshall WH, Murphy L, Rideout D, Taylor R, Xidos G, Larsen B.
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [Abstract] [Full Text] [Related]

  • 10. [HLA, A, B, C, DR, C4, Bf in insulin-dependent diabetics in the Tunisian population].
    Jenhani F, Bardi R, Gorgi Y, Ayed K, Chammaki S, Boukhris R.
    Ann Biol Clin (Paris); 1989 Apr; 47(1):23-8. PubMed ID: 2648900
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.
    Kelly H, McCann VJ, Kay PH, Dawkins RL.
    Immunogenetics; 1985 Apr; 22(6):643-51. PubMed ID: 3865895
    [Abstract] [Full Text] [Related]

  • 12. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S, O'Neill G, Dalmasso AP, Nerl C, Barbosa J.
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [Abstract] [Full Text] [Related]

  • 13. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.
    McCluskey J, McCann VJ, Kay PH, Zilko PJ, Christiansen FT, O'Neill GJ, Dawkins RL.
    Diabetologia; 1983 Mar; 24(3):162-5. PubMed ID: 6573286
    [Abstract] [Full Text] [Related]

  • 14. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B, Barolo P, Gadaleta G, Gamba Ansaldi S, Grassi G, Zerbinati A, Molinatti M, Salvetti E.
    Ann Osp Maria Vittoria Torino; 1984 Mar; 27(7-12):185-213. PubMed ID: 6443704
    [Abstract] [Full Text] [Related]

  • 15. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A, Ohayon E, Hauptmann G, Sevin A, Abbal M, Sommer E, Vergnes H, Ducos J.
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA and insulin-dependent juvenile diabetes mellitus.
    Májský A, Dvoráková L.
    Czech Med; 1983 May; 6(3):152-8. PubMed ID: 6416792
    [Abstract] [Full Text] [Related]

  • 18. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
    Mercier P, Vallo JJ, Vialettes B, Vague P.
    Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
    [Abstract] [Full Text] [Related]

  • 19. [The HLA system and insulin-dependent diabetes mellitus. A review and personal studies].
    Citro M, Gadaleta G, Gamba Ansaldi S, Molinatti M, Salvetti E, Bruni B.
    Ann Osp Maria Vittoria Torino; 1983 Jul; 26(1-6):108-42. PubMed ID: 6388459
    [Abstract] [Full Text] [Related]

  • 20. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD.
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.